Department of Cardiovascular Medicine Gifu Heart Center Gifu Japan.
Department of Cardiovascular Medicine Sapporo Cardio Vascular Clinic, Sapporo Heart Center Sapporo Japan.
J Am Heart Assoc. 2023 Oct 17;12(20):e030886. doi: 10.1161/JAHA.123.030886. Epub 2023 Oct 7.
Background Chronic kidney disease (CKD) might influence fractional flow reserve (FFR) value, potentially attenuating its prognostic utility. However, few large-scale data are available regarding clinical outcomes after FFR-guided deferral of revascularization in patients with CKD. Methods and Results From the J-CONFIRM registry (Long-Term Outcomes of Japanese Patients With Deferral of Coronary Intervention Based on Fractional Flow Reserve in Multicenter Registry), 1218 patients were divided into 3 groups according to renal function: (1) non-CKD (estimated glomerular filtration rate ≥60 mL/min per 1.73 m), n=385; (2) CKD (estimated glomerular filtration rate 15-59 mL/min per 1.73 m, n=763); and (3) end-stage renal disease (ESRD) (eGFR <15 mL/min per 1.73 m, n=70). The primary study end point was the cumulative 5-year incidence of target vessel failure (TVF), defined as a composite of cardiac death, target vessel myocardial infarction, and clinical driven target vessel revascularization. Cumulative 5-year incidence of TVF was significantly higher in the ESRD group than in the CKD and non-CKD group, whereas it did not differ between the CKD and non-CKD groups (26.3% versus 11.9% versus 9.5%, <0.001). Although the 5-year TVF risk increased as the FFR value decreased regardless of renal function, patients with ESRD had a remarkably higher risk of TVF at every FFR value than those with CKD and non-CKD. Conclusions At 5 years, patients with ESRD showed a higher incidence of TVF than patients with CKD and non-CKD, although with similar outcomes between patients with CKD and non-CKD. Patients with ESRD had an excess risk of 5-year TVF at every FFR value compared with those with CKD and non-CKD. Registration URL: https://www.umin.ac.jp; Unique identifier: UMIN000014473.
慢性肾病(CKD)可能会影响血流储备分数(FFR)值,从而降低其预后作用。然而,关于 CKD 患者接受 FFR 指导的血运重建延迟后的临床结局,目前仅有少量大规模数据。
来自 J-CONFIRM 注册研究(多中心基于血流储备分数的日本患者冠状动脉介入延迟的长期结果注册研究)的 1218 例患者根据肾功能分为 3 组:(1)非 CKD(估算肾小球滤过率[eGFR]≥60mL/min/1.73m²,n=385);(2)CKD(eGFR 为 15-59mL/min/1.73m²,n=763);(3)终末期肾病(ESRD)(eGFR<15mL/min/1.73m²,n=70)。主要研究终点是 5 年时的靶血管失败(TVF)累积发生率,定义为心脏死亡、靶血管心肌梗死和临床驱动的靶血管血运重建的复合终点。ESRD 组的 5 年 TVF 累积发生率明显高于 CKD 和非 CKD 组,而 CKD 和非 CKD 组之间无差异(26.3%比 11.9%比 9.5%,<0.001)。尽管无论肾功能如何,随着 FFR 值的降低,5 年 TVF 风险增加,但 ESRD 患者在每个 FFR 值时的 TVF 风险明显高于 CKD 和非 CKD 患者。
在 5 年时,ESRD 患者的 TVF 发生率高于 CKD 患者和非 CKD 患者,但 CKD 患者和非 CKD 患者的结局相似。与 CKD 患者和非 CKD 患者相比,ESRD 患者在每个 FFR 值时的 5 年 TVF 风险都更高。